arrow
Q

Qiang Zhou

ludong university
H指数:12
被引数:909

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China

卡多尼单抗联合铂类化疗加或不加贝伐单抗作为一线治疗持续性、复发性或转移性宫颈癌 (COMPASSION-16): 一项随机、双盲、安慰剂对照的中国3期临床试验

LANCET
IF88.5
2024-10-011
PRE